. Author manuscript; available in PMC: 2024 Jul 1.

Published in final edited form as: Hepatology. 2023 Feb 23;78(1):295–306. doi: 10.1097/HEP.0000000000000324

Table 1.

Baseline demographic and laboratory data of the study population.

	n	Alcohol-associated Hepatitis (n=26)
Gender (male), n	26	16 (61.5%)
Age (years)	26	48.6 [41.5;53.1]
BMI (kg/m²)	24	29.4 [25.4;34.5]
AST (IU/L)	26	150 [84.0;218]
ALT (IU/L)	26	50.5 [35.0;75.0]
GGT (IU/L)	14	400 [156;2288]
AP (IU/L)	26	182 [135;241]
Bilirubin (mg/dL)	26	13.8 [6.09;22.6]
Albumin (g/dL)	26	2.55 [2.12;2.88]
INR	26	1.90 [1.60;2.31]
Creatinine (mg/dL)	26	0.76 [0.59;1.19]
Platelets (10⁹/L)	26	138 [79.5;176]
MELD	26	23.5 [19.9;29.5]
FIB-4	26	6.34 [4.51;11.7]
FIB-4 > 3.25 (F3-F4), n	26	16 (61.5%)
Cytolysin positive, n	26	3 (11.5%)

Values are presented as median and interquartile range in brackets. The number of subjects for which data were available is indicated in the second column. ALT, alanine aminotransferase; AP, alkaline phosphatase; AST, aspartate aminotransferase; BMI, body mass index; FIB-4, Fibrosis-4 Index; GGT, gamma-glutamyltransferase; INR, international normalized ratio; MELD, model for end-stage liver disease.